참고문헌 (45)

1. Amanat F. White K.M. Miorin L. Strohmeier S. McMahon M. Meade P. Liu W.C. Albrecht R.A. Simon V. Martinez-Sobrido L. Moran T. Garcia-Sastre A. Krammer F. An in vitro microneutralization assay for SARS-CoV-2 serology and drug screening Curr. Protoc. Microbiol. 58 2020 e108 32585083 

2. Baker S.F. Nogales A. Santiago F.W. Topham D.J. Martinez-Sobrido L. Competitive detection of influenza neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay (BiFMA) Vaccine 33 2015 3562 3570 26044496 

3. Bauman J.D. Patel D. Baker S.F. Vijayan R.S. Xiang A. Parhi A.K. Martinez-Sobrido L. LaVoie E.J. Das K. Arnold E. Crystallographic fragment screening and structure-based optimization yields a new class of influenza endonuclease inhibitors ACS Chem. Biol. 8 2013 2501 2508 23978130 

4. Bogoch I.I. Watts A. Thomas-Bachli A. Huber C. Kraemer M.U.G. Khan K. Potential for global spread of a novel coronavirus from China J. Travel Med. 2020 27 

5. Brouillette R.B. Phillips E.K. Patel R. Mahauad-Fernandez W. Moller-Tank S. Rogers K.J. Dillard J.A. Cooney A.L. Martinez-Sobrido L. Okeoma C. Maury W. TIM-1 mediates dystroglycan-independent entry of Lassa virus J. Virol. 2018 92 

6. Buonaguro L. Tagliamonte M. Tornesello M.L. Buonaguro F.M. SARS-CoV-2 RNA polymerase as target for antiviral therapy J. Transl. Med. 18 2020 185 32370758 

   상세보기

7. Chary M.A. Barbuto A.F. Izadmehr S. Hayes B.D. Burns M.M. COVID-19: therapeutics and their toxicities J. Med. Toxicol. 16 2020 284 294 32356252 

   상세보기

8. Choy K.T. Wong A.Y. Kaewpreedee P. Sia S.F. Chen D. Hui K.P.Y. Chu D.K.W. Chan M.C.W. Cheung P.P. Huang X. Peiris M. Yen H.L. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro Antiviral Res. 178 2020 104786 

   상세보기

9. Elfiky A.A. Ribavirin, remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study Life Sci. 253 2020 117592 

10. Ferner R.E. Aronson J.K. Remdesivir in covid-19 BMJ 369 2020 m1610 32321732 

11. Fox R.I. Mechanism of action of hydroxychloroquine as an antirheumatic drug Semin. Arthritis Rheum. 23 1993 82 91 8278823 

    상세보기

12. Gordon C.J. Tchesnokov E.P. Feng J.Y. Porter D.P. Gotte M. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus J. Biol. Chem. 295 2020 4773 4779 32094225 

    상세보기

13. Imai M. Iwatsuki-Horimoto K. Hatta M. Loeber S. Halfmann P.J. Nakajima N. Watanabe T. Ujie M. Takahashi K. Ito M. Yamada S. Fan S. Chiba S. Kuroda M. Guan L. Takada K. Armbrust T. Balogh A. Furusawa Y. Okuda M. Ueki H. Yasuhara A. Sakai-Tagawa Y. Lopes T.J.S. Kiso M. Yamayoshi S. Kinoshita N. Ohmagari N. Hattori S.I. Takeda M. Mitsuya H. Krammer F. Suzuki T. Kawaoka Y. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development Proc. Natl. Acad. Sci. U.S.A. 2020 

14. Juurlink D.N. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection CMAJ 192 2020 E450 E453 32269021 

    상세보기

15. Li F. Structure, function, and evolution of coronavirus spike proteins Annu. Rev. Virol. 3 2016 237 261 27578435 

16. Martinez-Sobrido L. Cadagan R. Steel J. Basler C.F. Palese P. Moran T.M. Garcia-Sastre A. Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies J. Virol. 84 2010 2157 2163 19939917 

    상세보기

17. Masters P.S. The molecular biology of coronaviruses Adv. Virus Res. 66 2006 193 292 16877062 

    상세보기

18. Matsuyama S. Nao N. Shirato K. Kawase M. Saito S. Takayama I. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells PNAS 117 2020 7001 7003 32165541 

    상세보기

19. Montefiori D.C. Role of complement and Fc receptors in the pathogenesis of HIV-1 infection Springer Semin. Immunopathol. 18 1997 371 390 9089955 

    상세보기

20. Mortola E. Roy P. Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system FEBS Lett. 576 2004 174 178 15474033 

    상세보기

21. Nogales A. Baker S.F. Martinez-Sobrido L. Replication-competent influenza A viruses expressing a red fluorescent protein Virology 476 2015 206 216 25553516 

    상세보기

22. Nogales A. Rodriguez-Sanchez I. Monte K. Lenschow D.J. Perez D.R. Martinez-Sobrido L. Replication-competent fluorescent-expressing influenza B virus Virus Res. 213 2016 69 81 26590325 

    상세보기

23. Nogales A. Piepenbrink M.S. Wang J. Ortega S. Basu M. Fucile C.F. Treanor J.J. Rosenberg A.F. Zand M.S. Keefer M.C. Martinez-Sobrido L. Kobie J.J. A highly potent and broadly neutralizing H1 influenza-specific human monoclonal antibody Sci. Rep. 8 2018 4374 29531320 

    상세보기

24. Nogales A. Avila-Perez G. Rangel-Moreno J. Chiem K. DeDiego M.L. Martinez-Sobrido L. A novel fluorescent and bioluminescent bireporter influenza a virus to evaluate viral infections J. Virol. 2019 93 

25. Oladunni F.S. Sarkar S. Reedy S. Balasuriya U.B.R. Horohov D.W. Chambers T.M. Equid herpesvirus 1 targets the sensitization and induction steps to inhibit the type I interferon response in equine endothelial cells J. Virol. 2019 93 

26. Organization W.H. Coronavirus Disease 2019 (COVID-19) Situation Report-51 2020 https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10 

27. Ortiz-Riano E. Ngo N. Devito S. Eggink D. Munger J. Shaw M.L. de la Torre J.C. Martinez-Sobrido L. Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor J. Virol. 88 2014 878 889 24198417 

    상세보기

28. Park J.G. Avila-Perez G. Madere F. Hilimire T.A. Nogales A. Almazan F. Martinez-Sobrido L. Potent inhibition of zika virus replication by aurintricarboxylic acid Front. Microbiol. 10 2019 718 31031722 

    상세보기

29. Park J.G. Avila-Perez G. Nogales A. Blanco-Lobo P. de la Torre J.C. Martinez-Sobrido L. Identification and characterization of novel compounds with broad-spectrum antiviral activity against influenza A and B viruses J. Virol. 2020 94 

30. Park S.J. Yu K.M. Kim Y.I. Kim S.M. Kim E.H. Kim S.G. Kim E.J. Casel M.A.B. Rollon R. Jang S.G. Lee M.H. Chang J.H. Song M.S. Jeong H.W. Choi Y. Chen W. Shin W.J. Jung J.U. Choi Y.K. Antiviral efficacies of FDA-Approved drugs against SARS-CoV-2 infection in ferrets mBio 2020 11 

31. Perlman S. Netland J. Coronaviruses post-SARS: update on replication and pathogenesis Nat. Rev. Microbiol. 7 2009 439 450 19430490 

    상세보기

32. Piepenbrink M.S. Nogales A. Basu M. Fucile C.F. Liesveld J.L. Keefer M.C. Rosenberg A.F. Martinez-Sobrido L. Kobie J.J. Broad and protective influenza B virus neuraminidase antibodies in humans after vaccination and their clonal persistence as plasma cells mBio 2019 10 

33. Reihani H. Ghassemi M. Mazer-Amirshahi M. Aljohani B. Pourmand A. Non-evidenced based treatment: an unintended cause of morbidity and mortality related to COVID-19 Am. J. Emerg. Med. 2020 

34. Riou B. Barriot P. Rimailho A. Baud F.J. Treatment of severe chloroquine poisoning N. Engl. J. Med. 318 1988 1 6 3336379 

    상세보기

35. Robinson J.E. Hastie K.M. Cross R.W. Yenni R.E. Elliott D.H. Rouelle J.A. Kannadka C.B. Smira A.A. Garry C.E. Bradley B.T. Yu H. Shaffer J.G. Boisen M.L. Hartnett J.N. Zandonatti M.A. Rowland M.M. Heinrich M.L. Martinez-Sobrido L. Cheng B. de la Torre J.C. Andersen K.G. Goba A. Momoh M. Fullah M. Gbakie M. Kanneh L. Koroma V.J. Fonnie R. Jalloh S.C. Kargbo B. Vandi M.A. Gbetuwa M. Ikponmwosa O. Asogun D.A. Okokhere P.O. Follarin O.A. Schieffelin J.S. Pitts K.R. Geisbert J.B. Kulakoski P.C. Wilson R.B. Happi C.T. Sabeti P.C. Gevao S.M. Khan S.H. Grant D.S. Geisbert T.W. Saphire E.O. Branco L.M. Garry R.F. Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits Nat. Commun. 7 2016 11544 27161536 

    상세보기

36. Rodrigo W.W. de la Torre J.C. Martinez-Sobrido L. Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses J. Virol. 85 2011 1684 1695 21123370 

    상세보기

37. Rodriguez L. Nogales A. Martinez-Sobrido L. Influenza a virus studies in a mouse model of infection J. Vis. Exp. 2017 

38. Schoeman D. Fielding B.C. Coronavirus envelope protein: current knowledge Virol. J. 16 2019 69 31133031 

    상세보기

39. Shang J. Wan Y. Luo C. Ye G. Geng Q. Auerbach A. Cell entry mechanisms of SARS-CoV-2 Proc. Natl. Acad. Sci. U.S.A. 117 2020 11727 11734 32376634 

    상세보기

40. Wang C. Zheng X. Gai W. Zhao Y. Wang H. Wang H. Feng N. Chi H. Qiu B. Li N. Wang T. Gao Y. Yang S. Xia X. MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques Oncotarget 8 2017 12686 12694 27050368 

    상세보기

41. Wang C. Li W. Drabek D. Okba N.M.A. van Haperen R. Osterhaus A. van Kuppeveld F.J.M. Haagmans B.L. Grosveld F. Bosch B.J. A human monoclonal antibody blocking SARS-CoV-2 infection Nat. Commun. 11 2020 2251 32366817 

    상세보기

42. Wu F. Wang A. Liu M. Wang Q. Chen J. Xia S. Ling Y. Zhang Y. Xun J. Lu L. Neutralizing Antibody Responses to SARS-CoV-2 in a COVID-19 Recovered Patient Cohort and Their Implications 2020 

43. Xu J. Shi P.Y. Li H. Zhou J. Broad Spectrum Antiviral agent niclosamide and its therapeutic potential ACS Infect. Dis. 6 2020 909 915 32125140 

    상세보기

44. Yang H. Baker S.F. Gonzalez M.E. Topham D.J. Martinez-Sobrido L. Zand M. Holden-Wiltse J. Wu H. An improved method for estimating antibody titers in microneutralization assay using green fluorescent protein J. Biopharm. Stat. 26 2016 409 420 26010892 

    상세보기

45. Yao X. Ye F. Zhang M. Cui C. Huang B. Niu P. Liu X. Zhao L. Dong E. Song C. Zhan S. Lu R. Li H. Tan W. Liu D. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clin. Infect. Dis. 2020